25 May 2013
Keywords: aviron, appointments, biopharmaceutical, firm, david, wonnacott, ex-merck
Article | 17 August 2000
At US biopharmaceutical firm Aviron, David Wonnacott (ex-Merck &Co), takes on the post of vice, president regulatory affairs, and Charles ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.